GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Stonewyvvern@lemmy.worldEnglish
    8·
    8 months ago

    In the future, you have to subscribe to use your specific genes. No choice in the matter because you were born with them, but big pharma owns the rights to those same genes.